Use of polysaccharide hemostatic agent (HaemoCer™) in breast cancer surgery to reduce postoperative complications: A randomised controlled trial
Sign Up to like & getrecommendations! Published in 2022 at "International Wound Journal"
DOI: 10.1111/iwj.13939
Abstract: Postoperative wound‐site bleeding, tissue inflammation and seroma formation are well‐known complications in the field of breast surgery. Hemostatic agents consisting of polysaccharides may be used intra‐operatively to minimise postoperative complications. We conducted a prospective randomised‐controlled,… read more here.
Keywords: surgery; postoperative complications; breast; hemostatic agent ... See more keywords